Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$1.45 - $2.95 $49,955 - $101,633
-34,452 Reduced 7.05%
454,281 $690,000
Q4 2022

Feb 14, 2023

BUY
$2.02 - $3.25 $100,230 - $161,261
49,619 Added 11.3%
488,733 $1.17 Million
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.14 $204,931 - $328,308
104,557 Added 31.25%
439,114 $900,000
Q2 2022

Aug 12, 2022

BUY
$1.3 - $2.64 $209,595 - $425,639
161,227 Added 93.02%
334,557 $649,000
Q1 2022

May 16, 2022

SELL
$2.35 - $3.47 $101,132 - $149,331
-43,035 Reduced 19.89%
173,330 $426,000
Q4 2021

Feb 14, 2022

BUY
$2.92 - $5.74 $172,986 - $340,049
59,242 Added 37.7%
216,365 $696,000
Q3 2021

Nov 15, 2021

SELL
$4.98 - $6.63 $161,591 - $215,130
-32,448 Reduced 17.12%
157,123 $824,000
Q2 2021

Aug 16, 2021

BUY
$2.56 - $5.49 $6,545 - $14,037
2,557 Added 1.37%
189,571 $1.04 Million
Q1 2021

May 14, 2021

BUY
$2.69 - $5.25 $147,901 - $288,655
54,982 Added 41.64%
187,014 $508,000
Q3 2020

Nov 13, 2020

SELL
$2.98 - $5.2 $8,728 - $15,230
-2,929 Reduced 2.17%
132,032 $528,000
Q2 2020

Aug 14, 2020

SELL
$2.29 - $4.24 $144,095 - $266,797
-62,924 Reduced 31.8%
134,961 $530,000
Q1 2020

May 15, 2020

BUY
$1.92 - $4.39 $19,777 - $45,221
10,301 Added 5.49%
197,885 $484,000
Q4 2019

Feb 14, 2020

BUY
$2.41 - $4.4 $75,645 - $138,107
31,388 Added 20.1%
187,584 $763,000
Q3 2019

Nov 14, 2019

BUY
$2.17 - $3.14 $13,827 - $20,008
6,372 Added 4.25%
156,196 $402,000
Q2 2019

Aug 15, 2019

BUY
$2.53 - $3.04 $28,082 - $33,744
11,100 Added 8.0%
149,824 $0
Q1 2019

May 14, 2019

BUY
$2.51 - $3.73 $14,369 - $21,354
5,725 Added 4.3%
138,724 $0
Q2 2018

Aug 14, 2018

BUY
$2.26 - $4.65 $118,423 - $243,660
52,400 Added 65.01%
132,999 $0
Q1 2018

May 14, 2018

BUY
$3.51 - $6.04 $54,594 - $93,946
15,554 Added 23.91%
80,599 $0
Q4 2017

Feb 09, 2018

BUY
$3.26 - $4.78 $39,772 - $58,316
12,200 Added 23.09%
65,045 $0
Q3 2017

Nov 13, 2017

BUY
$3.48 - $4.44 $183,900 - $234,631
52,845
52,845 $0

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.